Methylene Blue, LDN, and Compounding Options for Inflammation
Compounding Innovations
•
49m
49 Min
Handout: https://bit.ly/4gWUFUz
During this presentation, Sara Hover, RPh, will discuss Methylene Blue, LDN, and compounding options for inflammation. After watching this presentation, the viewer should be able to:
•Examine the most recent methylene blue literature.
•Understand the role of low-dose naltrexone in depression and memory.
•Analyze the connection between the gut microbiota and mitochondria.
•Identify compounding options for chronic conditions.
Up Next in Compounding Innovations
-
Mebendazole & Ivermectin in Oncology
Download Handouts: https://bit.ly/4jkDKwj
We invite you to watch our FREE webinar to discover how the well-known antiparasitics, mebendazole and ivermectin, are being researched as potential options in cancer therapy.
What you’ll gain by attending:
• Expert insights into the mechanisms of acti...
